Subscribe
shutterstock_418900891_jejim
jejim / Shutterstock.com
26 March 2021AmericasAlex Baldwin

Fed Circ. affirms Stanford genetics patent rejection

The Federal Circuit has affirmed a Patent Trial and Appeal Board (PTAB) decision denying Stanford University a patent application for calculating parent genes.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
The increasing relevance of ‘technical character’
16 August 2022   Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP.
Americas
Federal Circuit affirms US university’s patent invalidations
19 July 2022   Kidney test patents detect “natural phenomena” | Delaware court grants Natera and Eurofins summary judgments on ineligibility.
Americas
Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent
15 March 2021   Stanford University can’t patent a genetic testing method as it is based on “abstract mathematical calculations”, the US Court of Appeals for the Federal Circuit has ruled.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
The increasing relevance of ‘technical character’
16 August 2022   Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP.
Americas
Federal Circuit affirms US university’s patent invalidations
19 July 2022   Kidney test patents detect “natural phenomena” | Delaware court grants Natera and Eurofins summary judgments on ineligibility.
Americas
Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent
15 March 2021   Stanford University can’t patent a genetic testing method as it is based on “abstract mathematical calculations”, the US Court of Appeals for the Federal Circuit has ruled.

More on this story

Big Pharma
The increasing relevance of ‘technical character’
16 August 2022   Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP.
Americas
Federal Circuit affirms US university’s patent invalidations
19 July 2022   Kidney test patents detect “natural phenomena” | Delaware court grants Natera and Eurofins summary judgments on ineligibility.
Americas
Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent
15 March 2021   Stanford University can’t patent a genetic testing method as it is based on “abstract mathematical calculations”, the US Court of Appeals for the Federal Circuit has ruled.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB